Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryotaro Nakamura

Showing results (51-60 of 244) with videos related to

Pageof 25
Sort By:
Transplantation and Cellular Therapy|June 16, 2026
The Effect of Belumosudil on the Therapeutic Drug Levels of Tacrolimus and Sirolimus in Allogeneic Hematopoietic TransplantationDat Ngo, Jose Tinajero, Karamjeet Sandhu, et al.
Transplantation and Cellular Therapy|May 4, 2025
Out-of-Pocket Expenditures and Financial Hardship Among Patients With Myelodysplastic Syndrome Undergoing Allogeneic Transplant or Hypomethylating Agent / Supportive Care (BMT CTN 1102)Christopher T Su, Wael Saber, Aasthaa Bansal, et al.
Bone Marrow Transplantation|September 26, 2019
Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantationMonzr M Al Malki, Ketevan Gendzekhadze, Tracey Stiller, et al.
Leukemia Research|October 24, 2019
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivationRyotaro Nakamura, Ketevan Gendzekhadze, Joycelynne Palmer, et al.
Transplantation and Cellular Therapy|July 18, 2021
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant RecipientsHaris Ali, Dat Ngo, Ahmed Aribi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2024
Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysisAisha A H Al-Jamaei, Joel B Epstein, Jan G A M de Visscher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2020
Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular DiseaseEllen Chang, Aleksi Iukuridze, Meagan Echevarria, et al.
Journal of Proteome Research|October 16, 2020
Prediction of Acute Graft versus Host Disease and Relapse by Endogenous Metabolomic Compounds in Patients Receiving Personalized Busulfan-Based ConditioningJeannine S McCune, Jožefa S McKiernan, Erik van Maarseveen, et al.
Frontiers in Oncology|December 19, 2022
Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapyColton Ladbury, Claire Hao, Dongyun Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2012
Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxisSepideh Shayani, Joycelynne Palmer, Tracey Stiller, et al.
Pageof 25

Showing results (51-60 of 244) with videos related to

Sort By:
Pageof 25
Transplantation and Cellular Therapy|June 16, 2026
The Effect of Belumosudil on the Therapeutic Drug Levels of Tacrolimus and Sirolimus in Allogeneic Hematopoietic TransplantationDat Ngo, Jose Tinajero, Karamjeet Sandhu, et al.
Transplantation and Cellular Therapy|May 4, 2025
Out-of-Pocket Expenditures and Financial Hardship Among Patients With Myelodysplastic Syndrome Undergoing Allogeneic Transplant or Hypomethylating Agent / Supportive Care (BMT CTN 1102)Christopher T Su, Wael Saber, Aasthaa Bansal, et al.
Bone Marrow Transplantation|September 26, 2019
Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantationMonzr M Al Malki, Ketevan Gendzekhadze, Tracey Stiller, et al.
Leukemia Research|October 24, 2019
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivationRyotaro Nakamura, Ketevan Gendzekhadze, Joycelynne Palmer, et al.
Transplantation and Cellular Therapy|July 18, 2021
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant RecipientsHaris Ali, Dat Ngo, Ahmed Aribi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2024
Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysisAisha A H Al-Jamaei, Joel B Epstein, Jan G A M de Visscher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2020
Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular DiseaseEllen Chang, Aleksi Iukuridze, Meagan Echevarria, et al.
Journal of Proteome Research|October 16, 2020
Prediction of Acute Graft versus Host Disease and Relapse by Endogenous Metabolomic Compounds in Patients Receiving Personalized Busulfan-Based ConditioningJeannine S McCune, Jožefa S McKiernan, Erik van Maarseveen, et al.
Frontiers in Oncology|December 19, 2022
Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapyColton Ladbury, Claire Hao, Dongyun Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2012
Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxisSepideh Shayani, Joycelynne Palmer, Tracey Stiller, et al.
Pageof 25